0 Comentários
0 Compartilhamentos
678 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Faça Login para curtir, compartilhar e comentar!
-
Cancer Biologics Market Advances with Growing Innovation in Targeted Therapies and Next-Generation BiopharmaceuticalsAccording to the latest report published by Data Bridge Market Research, the Cancer Biologics Market The global cancer biologics market size was valued at USD 122.55 billion in 2024 and is projected to reach USD 195.62 billion by 2032, with a CAGR of 6.02% during the forecast period of 2025 to 2032. An influential Cancer Biologics Market advertising report puts light on the types...0 Comentários 0 Compartilhamentos 1K Visualizações 0 Anterior
-
Ensartinib Hydrochloride Market: Strong Growth Driven by Expanding Oncology Applications, FDA Approval for ALK-Positive NSCLC, and Rising Demand for Next-Generation Targeted Cancer TherapiesThe Ensartinib Hydrochloride Market is experiencing strong growth as oncology applications expand, FDA approval for ALK-positive non-small cell lung cancer (NSCLC) is secured, and demand for next-generation targeted cancer therapies continues to rise. The global market was valued at approximately USD 0.48–0.6 billion in 2023–2024 and is projected to reach between USD 1.09 billion...0 Comentários 0 Compartilhamentos 884 Visualizações 0 Anterior
-
High-Potency Oncology API (HPAPI) Market Size Expected to Grow Significantly During 2026–2032 Driven by Rising Demand for Targeted Cancer Therapies"High-Potency Oncology API (HPAPI) Market Summary: According to the latest report published by Data Bridge Market Research, the High-Potency Oncology API (HPAPI) Market The global High-Potency Oncology API (HPAPI) market size was valued at USD 693 Million in 2025 and is expected to reach USD 1421.90 Million by 2033, at a CAGR of 9.40% during the forecast period The reliable...0 Comentários 0 Compartilhamentos 1K Visualizações 0 Anterior
-
How Are Targeted Therapies Advancing the Bone Cancer Drug Market?According to the latest report published by Data Bridge Market Research, the Bone Cancer Drug Market CAGR Value The global bone cancer drug market size was valued at USD 1.35 billion in 2024 and is projected to reach USD 1.98 billion by 2032, with a CAGR of 4.96% during the forecast period of 2025 to 2032 The idea of this Bone Cancer Drug Market research document is high...0 Comentários 0 Compartilhamentos 819 Visualizações 0 Anterior
-
Janus Kinases (JAKs) Inhibitor Drugs Market Size, Share, Growth Trends, Industry Analysis, and Forecast 2026–2032 Driven by Rising Prevalence of Autoimmune Disorders and Advancements in Targeted TherapiesAccording to the latest report published by Data Bridge Market Research, the Janus Kinases (JAKs) Inhibitor Drugs Market Data Bridge Market Research analyses that the Janus kinases (JAKs) inhibitor drugs market, which is USD 2.45 billion in 2022, is expected to reach USD 5.11 billion by 2030, at a CAGR of 9.6% during the forecast period 2023 to 2030. This Janus Kinases (JAKs)...0 Comentários 0 Compartilhamentos 1K Visualizações 0 Anterior
-
Market Overview – The Rise of HDAC8-Targeted TherapiesThe global Histone Deacetylase 8 Market is on a robust growth trajectory, driven by the increasing recognition of HDAC8 as a key epigenetic target in oncology, neurology, and rare diseases. According to a comprehensive report by Wise Guy Reports, the market was valued at USD 500 million in 2024. It is projected to grow from USD 500 million in 2025 to USD 1,500 million by 2035,...0 Comentários 0 Compartilhamentos 1K Visualizações 0 Anterior
-
Orthostatic Hypotension Drugs Market Advances with Rising Demand for Targeted Therapies and Improved Cardiovascular CareAccording to the latest report published by Data Bridge Market Research, the Orthostatic Hypotension Drugs Market Data Bridge Market Research analyses that the orthostatic hypotension drugs market, which was USD 744.93 million in 2022, is expected to reach USD 1,313.81 million by 2030, at a CAGR of 7.35% during the forecast period 2023 to 2030. Winning Orthostatic Hypotension Drugs...0 Comentários 0 Compartilhamentos 807 Visualizações 0 Anterior
-
Phelan McDermid Syndrome Market: How Are SHANK3-Targeted Therapies and IGF-1 Analogues Opening Therapeutic Avenues for Autism-Related Genetic Disorders?Phelan-McDermid syndrome — the neurodevelopmental disorder caused by deletion or mutation of the SHANK3 gene on chromosome 22q13.3, characterized by severe intellectual disability, autism spectrum disorder, hypotonia, speech absence, and seizures — has historically been managed entirely through supportive and behavioral interventions, but the Phelan McDermid Syndrome Market is now...0 Comentários 0 Compartilhamentos 728 Visualizações 0 Anterior
-
Polycythemia Vera Market Expands with Advancements in Targeted Therapies and Personalized Hematology CareAccording to the latest report published by Data Bridge Market Research, the Polycytomia Vera Market The global Polycytomia Vera market size was valued at USD 1.35 billion in 2025and is expected to reach USD 1.99 billion by 2033, at a CAGR of 5.00% during the forecast period The persuasive Polycytomia Vera Market report covers several topics including market trend analysis,...0 Comentários 0 Compartilhamentos 884 Visualizações 0 Anterior
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
